You are here: Industry Insights > Serum Institute

News List

Serum Institute seeks DCGI nod for phase2/3 trials of Oxford’s COVID-19 vaccine expresspharma
July 27, 2020
According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covidshield' in healthy Indian adults.
Serum Institute gets DCGI nod for pneumococcal polysaccharide conjugate vaccine expresspharma
July 16, 2020
The Drug Controller General of India (DCGI) has given approval to the first fully indigenously developed pneumococcal polysaccharide conjugate vaccine.
Serum Institute to invest $100 million on potential COVID-19 vaccine expresspharma
June 10, 2020
It has partnered with AstraZeneca, a British company, to ensure equitable supply of the AZD1222 vaccine doses to India as well as low-and-middle-income countries.
Serum Institute plans to price coronavirus vaccine at ₹1,000 if trials succeed expresspharma
April 29, 2020
The Serum Institute of India announced that it plans this year to produce up to 60 million doses of a potential vaccine against the new coronavirus that is under clinical trial in Britain.
Plans afoot to develop COVID-19 vaccine at the earliest: Dr Harsh Vardhan expresspharma
April 27, 2020
Serum Institute of India is collaborating with Oxford University to make the Covid-19 vaccine.
Serum Institute plans COVID-19 vaccine by 2022 expresspharma
March 12, 2020
States the need for fast-tracking of regulatory clearances for the vaccine.
Codagenix and Serum Institute of India Initiate Co-Development of a Scalable, Live-Attenuated Vaccine Against the 2019 Novel Coronavirus, COVID-19 PRNewswire
February 14, 2020
There are no licensed vaccines or therapeutics for this novel coronavirus, now referred to as COVID-19.
New pneumococcal vaccine from Serum Institute of India achieves WHO prequalification firstwordpharma
December 22, 2019
Prequalification allows PNEUMOSIL® to be procured by United Nations agencies and Gavi, the Vaccine Alliance.
Dyadic, Serum Institute of India collaborate for antibodies and vaccines biospectrumasia
May 15, 2019
Under the terms of this collaboration, Serum anticipates applying Dyadic's C1 technology to express up to twelve proteins - 8 MABs and 4 rVaccines and will undertake commercially best efforts to fully develop and commercialize the proteins expressed from
Serum Institute to launch 4 vaccines, enter US, Europe markets indiatimes
December 08, 2017
Homegrown global vaccines major Serum Institute of India plans to launch at least four products and enter European and US markets in the next three to four years as it seeks to retain number one position.

Previous page 1 2 3 Next page